Omeros
Pre-clinicalOmeros discovers and develops small-molecule and antibody therapeutics targeting inflammation, immunology, and central nervous system disorders.
Founded
1994
Focus
Small Molecules
About
Omeros discovers and develops small-molecule and antibody therapeutics targeting inflammation, immunology, and central nervous system disorders.
Funding History
3Total raised: $317M
Debt$125MAthyrion Capital ManagementMar 15, 2021
PIPE$150MUndisclosedDec 15, 2020
IPO$42MUndisclosedOct 22, 2009
Company Info
TypePrivate
Founded1994
LocationSeattle, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile